Cover Image

MAP kinase pathway gene copy alterations in NRAS/BRAF wild-type advanced melanoma

Recent therapeutic advances have improved melanoma patientś clinical outcome. Novel therapeutics targeting BRAF, NRAS and cKit mutant melanomas are widely used in clinical practice. However therapeutic options in NRASwild-type/BRAFwild-type/cKitwild-type melanoma patients are limited. Our study sho...

Full description

Saved in:
Bibliographic Details
Main Authors: Orouji, Elias (Author) , Orouji, Azadeh (Author) , Gaiser, Timo (Author) , Gebhardt, Christoffer (Author) , Utikal, Jochen (Author)
Format: Article (Journal)
Language:English
Published: 2016
In: International journal of cancer
Year: 2015, Volume: 138, Issue: 9, Pages: 2257-2262
ISSN:1097-0215
DOI:10.1002/ijc.29970
Online Access:Verlag, Volltext: https://doi.org/10.1002/ijc.29970
Verlag, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.29970
Get full text
Author Notes:Elias Orouji, Azadeh Orouji, Timo Gaiser, Lionel Larribère, Christoffer Gebhardt and Jochen Utikal

MARC

LEADER 00000caa a2200000 c 4500
001 1665500441
003 DE-627
005 20220816152345.0
007 cr uuu---uuuuu
008 190514r20162015xx |||||o 00| ||eng c
024 7 |a 10.1002/ijc.29970  |2 doi 
035 |a (DE-627)1665500441 
035 |a (DE-599)KXP1665500441 
035 |a (OCoLC)1341220746 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Orouji, Elias  |d 1982-  |e VerfasserIn  |0 (DE-588)112948257X  |0 (DE-627)884088006  |0 (DE-576)486431282  |4 aut 
245 1 0 |a MAP kinase pathway gene copy alterations in NRAS/BRAF wild-type advanced melanoma  |c Elias Orouji, Azadeh Orouji, Timo Gaiser, Lionel Larribère, Christoffer Gebhardt and Jochen Utikal 
264 1 |c 2016 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 14.05.2019 
500 |a Online 18 Dec 2015 
520 |a Recent therapeutic advances have improved melanoma patientś clinical outcome. Novel therapeutics targeting BRAF, NRAS and cKit mutant melanomas are widely used in clinical practice. However therapeutic options in NRASwild-type/BRAFwild-type/cKitwild-type melanoma patients are limited. Our study shows that gene copy numbers of members of the MAPK signaling pathway vary in different melanoma subgroups. NRASwild-type/BRAFwild-type melanoma metastases are characterized by significant gains of MAP2K1 (MEK1) and MAPK3 (ERK1) gene loci. These additional gene copies could lead to an activation of the MAPK signaling pathway via a gene-dosage effect. Our results suggest that downstream analyses of the pMEK and pERK expression status in NRASwild-type/BRAFwild-type melanoma patients identify patients that could benefit from targeted therapies with MEK and ERK inhibitors. 
534 |c 2015 
650 4 |a BRAF 
650 4 |a ERK 
650 4 |a MEK 
650 4 |a melanoma 
650 4 |a NRAS 
700 1 |a Orouji, Azadeh  |d 1979-  |e VerfasserIn  |0 (DE-588)141346167  |0 (DE-627)703953494  |0 (DE-576)323199712  |4 aut 
700 1 |a Gaiser, Timo  |d 1975-  |e VerfasserIn  |0 (DE-588)1030402280  |0 (DE-627)735221685  |0 (DE-576)378226533  |4 aut 
700 1 |a Gebhardt, Christoffer  |d 1976-  |e VerfasserIn  |0 (DE-588)13051151X  |0 (DE-627)503031666  |0 (DE-576)298240289  |4 aut 
700 1 |a Utikal, Jochen  |d 1974-  |e VerfasserIn  |0 (DE-588)1026463750  |0 (DE-627)726765015  |0 (DE-576)371816580  |4 aut 
773 0 8 |i Enthalten in  |t International journal of cancer  |d Bognor Regis : Wiley-Liss, 1966  |g 138(2016), 9, Seite 2257-2262  |h Online-Ressource  |w (DE-627)269532781  |w (DE-600)1474822-8  |w (DE-576)079876129  |x 1097-0215  |7 nnas  |a MAP kinase pathway gene copy alterations in NRAS/BRAF wild-type advanced melanoma 
773 1 8 |g volume:138  |g year:2016  |g number:9  |g pages:2257-2262  |g extent:6  |a MAP kinase pathway gene copy alterations in NRAS/BRAF wild-type advanced melanoma 
856 4 0 |u https://doi.org/10.1002/ijc.29970  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.29970  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20190514 
993 |a Article 
994 |a 2016 
998 |g 1026463750  |a Utikal, Jochen  |m 1026463750:Utikal, Jochen  |d 60000  |e 60000PU1026463750  |k 0/60000/  |p 6  |y j 
998 |g 13051151X  |a Gebhardt, Christoffer  |m 13051151X:Gebhardt, Christoffer  |d 60000  |d 61900  |e 60000PG13051151X  |e 61900PG13051151X  |k 0/60000/  |k 1/60000/61900/  |p 5 
998 |g 1030402280  |a Gaiser, Timo  |m 1030402280:Gaiser, Timo  |d 60000  |d 63400  |e 60000PG1030402280  |e 63400PG1030402280  |k 0/60000/  |k 1/60000/63400/  |p 3 
998 |g 141346167  |a Orouji, Azadeh  |m 141346167:Orouji, Azadeh  |d 60000  |d 61900  |e 60000PO141346167  |e 61900PO141346167  |k 0/60000/  |k 1/60000/61900/  |p 2 
999 |a KXP-PPN1665500441  |e 3475813262 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Gesehen am 14.05.2019","Online 18 Dec 2015"],"recId":"1665500441","id":{"doi":["10.1002/ijc.29970"],"eki":["1665500441"]},"title":[{"title":"MAP kinase pathway gene copy alterations in NRAS/BRAF wild-type advanced melanoma","title_sort":"MAP kinase pathway gene copy alterations in NRAS/BRAF wild-type advanced melanoma"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedKey":"2016","dateIssuedDisp":"2016"}],"language":["eng"],"relHost":[{"titleTranslated":[{"translated":"Journal international du cancer"}],"recId":"269532781","pubHistory":["1.1966 -"],"titleAlt":[{"title":"Predictive oncology"}],"corporate":[{"role":"isb","display":"International Union against Cancer","roleDisplay":"Herausgebendes Organ"}],"origin":[{"publisher":"Wiley-Liss","publisherPlace":"Bognor Regis","dateIssuedKey":"1966","dateIssuedDisp":"1966-"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"part":{"pages":"2257-2262","extent":"6","year":"2016","volume":"138","issue":"9","text":"138(2016), 9, Seite 2257-2262"},"id":{"eki":["269532781"],"doi":["10.1002/(ISSN)1097-0215"],"zdb":["1474822-8"],"issn":["1097-0215"]},"title":[{"title_sort":"International journal of cancer","title":"International journal of cancer","subtitle":"publication of the International Union against Cancer (UICC) = Journal international du cancer"}],"disp":"MAP kinase pathway gene copy alterations in NRAS/BRAF wild-type advanced melanomaInternational journal of cancer","note":["Gesehen am 28.02.08","Darin: Predictive oncology"]}],"physDesc":[{"extent":"6 S."}],"person":[{"role":"aut","display":"Orouji, Elias","given":"Elias","family":"Orouji","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","family":"Orouji","given":"Azadeh","role":"aut","display":"Orouji, Azadeh"},{"display":"Gaiser, Timo","role":"aut","given":"Timo","family":"Gaiser","roleDisplay":"VerfasserIn"},{"given":"Christoffer","display":"Gebhardt, Christoffer","role":"aut","roleDisplay":"VerfasserIn","family":"Gebhardt"},{"display":"Utikal, Jochen","role":"aut","given":"Jochen","roleDisplay":"VerfasserIn","family":"Utikal"}],"name":{"displayForm":["Elias Orouji, Azadeh Orouji, Timo Gaiser, Lionel Larribère, Christoffer Gebhardt and Jochen Utikal"]}} 
SRT |a OROUJIELIAMAPKINASEP2016 

Similar Items